Transcat, Inc. (NASDAQ:TRNS) Forecasted to Post FY2025 Earnings of $1.88 Per Share

Transcat, Inc. (NASDAQ:TRNSFree Report) – HC Wainwright reduced their FY2025 EPS estimates for shares of Transcat in a research note issued on Wednesday, May 22nd. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will earn $1.88 per share for the year, down from their prior estimate of $2.31. HC Wainwright has a “Buy” rating and a $156.00 price objective on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.98 per share.

TRNS has been the subject of a number of other reports. Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Oppenheimer upped their price objective on shares of Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research note on Wednesday. TheStreet raised shares of Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st. Finally, Northland Capmk lowered shares of Transcat from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $134.50.

Check Out Our Latest Analysis on TRNS

Transcat Price Performance

NASDAQ TRNS traded up $2.60 on Friday, reaching $137.07. The company’s stock had a trading volume of 7,667 shares, compared to its average volume of 39,512. Transcat has a twelve month low of $81.26 and a twelve month high of $147.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.81 and a current ratio of 3.37. The stock has a market cap of $1.21 billion, a PE ratio of 86.21 and a beta of 0.61. The firm’s 50 day moving average is $113.66 and its two-hundred day moving average is $106.14.

Insider Activity

In related news, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction that occurred on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total value of $264,423.39. Following the transaction, the chief executive officer now owns 103,688 shares in the company, valued at $11,553,953.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Transcat news, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction that occurred on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the transaction, the chief executive officer now owns 103,688 shares in the company, valued at $11,553,953.84. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Lee D. Rudow sold 3,343 shares of the stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $124.12, for a total value of $414,933.16. Following the completion of the sale, the chief executive officer now directly owns 103,692 shares of the company’s stock, valued at $12,870,251.04. The disclosure for this sale can be found here. 4.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of TRNS. Commonwealth Equity Services LLC raised its stake in Transcat by 4.2% during the third quarter. Commonwealth Equity Services LLC now owns 4,377 shares of the scientific and technical instruments company’s stock worth $429,000 after acquiring an additional 175 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Transcat by 9.2% during the third quarter. Bank of New York Mellon Corp now owns 32,762 shares of the scientific and technical instruments company’s stock worth $3,210,000 after buying an additional 2,759 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Transcat by 31.1% during the third quarter. Principal Financial Group Inc. now owns 3,084 shares of the scientific and technical instruments company’s stock worth $302,000 after buying an additional 731 shares during the last quarter. Arizona State Retirement System bought a new position in Transcat during the third quarter worth about $213,000. Finally, Quantbot Technologies LP lifted its holdings in shares of Transcat by 118.2% during the 3rd quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock valued at $232,000 after purchasing an additional 1,284 shares in the last quarter. 98.34% of the stock is owned by institutional investors.

About Transcat

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Articles

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.